Key result
A bibliometric analysis of 440 publications from 1988 to 2024 revealed that China and the United States are the leading contributors to research on mitochondria in diabetic cardiomyopathy.
Why the study?
A bibliometric analysis focusing on the nexus between mitochondria and diabetic cardiomyopathy had not been conducted, leaving a gap in understanding holistic research trends.
This bibliometric analysis highlights a growing global research interest in the role of mitochondria in diabetic cardiomyopathy, with China and the United States leading publication output.
First bibliometric map of mitochondrial-DCM research; leaves open prioritization of therapeutic targets for prospective validation.
BACKGROUND: Diabetic Cardiomyopathy (DCM) is a distinct form of heart disease whose pathogenesis remains largely elusive. Recent studies have shed light on the significant role of mitochondria in the development of DCM, emphasizing their critical involvement. Despite these advancements, a bibliometric analysis focusing on the nexus between mitochondria and DCM has not been conducted, leaving a gap in a holistic understanding of research trends in this field. METHODS: This study extracted publications addressing the role of mitochondria in DCM from the Web of Science Core Collection, spanning from 1988 to 2024. A detailed bibliometric analysis was undertaken using tools like CiteSpace, VOSviewer, Microsoft Excel, and Tableau Public to assess the data. RESULTS: The analysis encompassed 440 publications involving 2705 researchers from 1457 institutions across 175 countries/regions. These studies were disseminated across 202 journals. China was the most prolific country with 192 publications, followed by the United States with 156, and Canada with 26. E. Dale Abel emerged as the most prolific author in this area. Key journals contributing to this research included the American Journal of Physiology-Heart and Circulatory Physiology and the Journal of Molecular and Cellular Cardiology. The future research direction is likely to focus deeper into the mechanisms of mitochondrial dysfunction in the diabetic heart and to identify molecular and cellular targets for therapeutic intervention. CONCLUSION: This report presents the first detailed bibliometric review of the intersection between mitochondrial research and DCM. It offers critical insights and guidance for researchers aiming to navigate and contribute to this evolving area of study.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied Diabetic Cardiomyopathy (n=440). Mitochondrial research in diabetic cardiomyopathy was evaluated on Bibliometric trends (publications, countries, authors, keywords). A bibliometric analysis of 440 publications from 1988 to 2024 revealed that China and the United States are the leading contributors to research on mitochondria in diabetic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: